O—（1—甲硫基乙叉胺基）硫代磷酰胺（酯）的合成及生物活性…

首次报道了甲硫基乙醛肟与硫代磷酰氯的缩合反应，合成了１６种新型Ｏ－（１－甲硫基乙叉胺基）硫代磷酰胺酯及硫代磷酸酯类化合物，化合物６ｂ具有很好的杀虫活性。     

有机硫代磷(膦)酸铵盐与三氯氧磷的氯化反应──合成硫(酮)代磷(膦)酰氯的一种新的简便方法

O,O二烷基硫代磷(膦)酸衍生物与二甲胺水溶液发生去烷基反应后,生成的硫代磷(膦)酸铵盐与三氯氧磷发生氯化反应,得到硫(酮)代磷(膦)酰氯.本文还讨论了该反应可能的机理.     

硫代磷(膦)酸酯的合成研究进展

硫代磷(膦)酸酯在农药、医药以及有机合成等研究领域具有广泛应用.重点总结了由P(O)—H化合物出发合成硫代磷(膦)酸酯类化合物的研究方法,按硫元素的不同来源分类,对该类反应的研究进展进行综述.     

O-烷基,O-芳基硫代磷酰取代硫脲和O-烷基硫代磷酰-双-取代硫脲的研究(Ⅱ)

用硫氰酸钾与硫代磷酰氯制备了硫代磷酰异硫氰基酯和二异硫氰基酯,并以其与不同胺反应,合成了硫代磷酰取代硫脲和硫代磷酰-双-取代硫脲两系列20个新的有机磷化合物,经1HNMR、IR及元素分析确定了它们的化学结构,测定了它们的生物活性。结果表明只有O-异丙基,O-(4-甲基-2-硝基苯基)-N''-萘基硫代磷酰硫脲(PD-1)具有较好的杀菌活性。     

O-[3-(2′-或4′-吡啶)丙基]硫代磷(膦)酸酯及硫代磷酰胺酯类化合物的研究

用O,O-二烷基硫代磷酰氯,O-烷基胺基硫代磷酰氯及O-烷基(或芳基)苯基硫代膦酰氯与3-(2′-或4′-吡啶)丙醇缩合制备了相应的硫代磷酸脂,硫代磷酰胺酯共十八个新化合物。测定了它们的红外光谱和核磁共振谱,探索了适宜的反应条件及产物的提纯方法。经初步测试表明某些化合物具有植物激素的活性。     

硫代磷(膦)酰基脲类衍生物的合成及其生物活性

通过O,O-二乙基硫代磷酰基异氰酸酯或O-乙基-苯基硫代膦酰基异氰酸酯与不同胺的加成反应,合成了一系列新型硫代磷(膦)酰基脲类化合物,其结构经元素分析、¹HNMR及MS确证。初步的生物活性测定表明,这类化合物具有一定的除草、抗肿瘤及抑制几丁质形成活性。     

S-烷基-O-多氯苯基硫代磷(膦)酸衍生物的合成及杀菌活性研究

O,O-二烷基硫代磷(膦)酸酯与三氯氧磷发生异构化氯化反应生成S-烷基硫代磷(膦)酰氯,后者在缚酸剂存在下与多氯酚反应得到标题化合物。此类化合物也可以用传统方法,从S-烷基硫代磷酰二氯先后与多氯酚及其它亲核试剂反应得到。对所合成的28个新化合物的平碟试验表明,在0.005%浓度下对小麦赤霉等12种植物病菌均表现了明显的抑制活性。     

2,7,12,17-四(甲硫基)-3,8,13,18-四(苯甲酰硫基)四氮杂卟啉及其Mg(Ⅱ)、Cu(Ⅱ)、Ni(Ⅱ)配合物的合成与表征

硫杂酞菁、含硫取代基的四氮杂卟啉及其金属配合物由于具有优异的光、电及催化性能而日益受到重视.据此,我们以自制的1-甲硫基-2-苯甲酰硫基马来二腈(MBM)为原料,合成了2,7,12,17-四(甲硫基)-3,8,13,18-四(苯甲酸硫基)四氮杂卟啉H_2T(mbm)TAP及其Mg(Ⅱ)、Cu(Ⅱ)、Ni(Ⅱ)配合物MT(mbm)TAP,经IR、UV-Vis和DTA等进行了表征.     

惰性C(sp~3)—H键的直接三氟甲硫基化

<正>Angew.Chem.Int.Ed.2015,54,4070~4074三氟甲硫基具有强的吸电子性和亲脂性,将其引入到分子中能够明显地改变母体分子的理化性质进而影响到生物活性,因此含三氟甲硫基的分子在医药、农药及材料等领域受到极大的关注.近些年来发展了许多向分子中引入三氟甲硫基的方法,但大多需要对底物进行预官能团化,发展温和条件下直接高效地向分子中引入三氟甲硫基的方法一直是科学家们追求的目标.从实用和原子经济性的角度来看,C—H键活化三氟甲硫基化是最直接高效的方法.     

O-烷基-O-(2'-甲酰缩氨基硫脲苯基)-N-烷基硫代磷酰胺的合成 (-)

本文报道了O-烷基-O-(2'-甲酰缩氨基硫脲苯基)-N-烷基硫代磷酰胺类化合物的合成方法, 化合物3c和3e具有良好的除草活性。     

Two New 4‐Hydroxyisoflavanes from the Root of Codonopsis cordifolioidea and Their Anti‐virus Activities

Two new 4‐hydroxyisoflavanes, cordifoliflavanes A and B (1 and 2), were isolated from the roots of Codonopsis cordifolioidea. Their structures were elucidated by spectroscopic methods, including extensive 1D‐ and 2D‐NMR techniques. Compounds 1 and 2 were tested for their anti‐HIV‐1 activities and anti‐tobacco mosaic virus activities. The results showed that compounds 1 and 2 have modest anti‐HIV‐1 activities and anti‐tobacco mosaic virus activities, respectively.     

The synthesis and photolarvicidal activity of 2,5-diarylethynylthiophenes

The photoactivatable insecticides have photoactive features and broad applications. The derivatives of the alpha-terthienyl analogues were synthesized for evaluating their photolarvicidal activities and 13 2,5-diarylethynylthiophenes were investigated to determine their effect on the second-instar larvae of Plutella xylostella L. Based on their photolarvicidal activities, the 2,5-Dithienylethynylthiophene, 2,5-Diphenylethynylthiophene, 2,5-Di-4-Methoxylphenylethynylthiophene and 2,5-Di-3,4-Methylenedioxyphenylethynylthiophene were found to be the most potent compounds, and their LC(50) values were 34.1 mg l(-1), 48.4 mg l(-1), 60.8 mg l(-1) and 42.7 mg l(-1), respectively. The relationship analysis between structure and activity showed that the middle thiophene ring played an important role on the activities. The electron donor substituents increased the photolarvicidal activities and the length of the alkyl chain had negative influence on the activities.     

天然5,7-二羟基-3-异戊烯基黄酮与5-羟基-3-异戊烯基黄酮的全合成

以2,4,6-三羟基苯乙酮和2,6-二羟基苯乙酮为原料, 分别通过甲基保护酚羟基、 苯甲酰氯酰化、 Bake-Venkataraman重排、 异戊烯基化、 酸催化关环及EtSLi脱去甲基等6步反应, 以高收率完成了天然5,7-二羟基-3-异戊烯基黄酮(1a, 收率80.6%)和5-羟基-3-异戊烯基黄酮(1b, 收率84.9%)的全合成, 所有化合物均经 ¹H NMR 和 ¹³C NMR表征确定. 通过密度泛函理论方法对目标产物(1a和1b)的生物活性进行了预测. 结果表明, 3位异戊烯基侧链的存在能大大增强化合物相应的生物活性, 而且是化合物生物活性增强必需的取代基. 另外, 目标产物1a的生物活性高于产物1b, 归因于黄酮类化合物分子中A环上的7-OH属增效基团, 起到增强生物活性的作用, 化合物1a分子中A环上有7-OH, 而化合物1b分子中则无该基团. 本合成方法对其它3-烃基黄酮类天然化合物的合成具有潜在的适用性, 所预测的生物活性结果为3-烃基黄酮类化合物的构效关系研究奠定了基础.     

1-(取代吡唑-4-甲酰基)吡唑类化合物的合成及生物活性研究

设计合成了25个新型1-取代吡唑甲酰基吡唑系列衍生物,化合物结构经¹HNMR、元素分析、IR和MS确证.生物活性测试结果表明,该类化合物具有一定除草活性,讨论了其结构与活性的关系.     

新型汉防己甲素衍生物的合成及其生物活性

以汉防己甲素为原料,经溴代反应制得关键中间体5-溴汉防己甲素(2); 2与硼酸衍生物经Suzuki反应合成了6个新型的汉防己甲素衍生物(4a~4f),其结构经¹H NMR, ¹³C NMR和ESI-MS表征。采用CCK-8法初步考察了4a~4f对人早幼粒白血病细胞(HL60)和人肺癌细胞(A549)的抑制活性;并采用MTT法对活性较好的化合物进行复筛。采用酶联免疫吸附法考察4a~4f对多种受体酪氨酸激酶的抑制活性。结果表明：4b, 4c和4e对HL60和A549有一定的抑制活性; 4b和4c对受体酪氨酸激酶FGFR1的抑制活性大于50%。     

Studies on non-thiazolidinedione antidiabetic agents. 3. Preparation and biological activity of the metabolites of TAK-559

Preparation and biological activity of the metabolites of the potent antihyperglycemic and antihyperlipidemic agent, (E)-4-(4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino)-4-phenylbutyric acid (TAK-559) (1), were investigated. Metabolites M-I (2), M-II (3), M-III (4) and M-IV (5) were synthesized and their biological activities were evaluated by in vitro and in vivo experiments. Compounds 2-4 activate human peroxisome proliferator-activated receptor gamma one (hPPARgamma1) and hPPARalpha, but their activities are weaker than those of TAK-559 (1). Compound 5 only activates hPPARgamma1 weakly. TAK-559 (1) showed potent in vivo plasma glucose and triglyceride lowering activities in Wistar fatty rats after intraperitoneal administration, while its metabolites (2-5) showed comparatively weak activities.     

A novel way of therapeutic angiogenesis using an adeno-associated virus-mediated angiogenin gene transfer

To develop a novel therapeutic angiogenesis for the treatment of cardiovascular diseases, angiogenin (ANG1) was examined as a potential therapeutic gene. An adeno-associated virus (AAV)-mediated gene delivery system was used to measure the therapeutic efficacy of ANG1. Using a triple co-transfection technique, rAAV-ANG1-GFP, rAAV- VEGF-GFP and rAAV-GFP vectors were produced, which were then used to infect human umbilical vein endothelial cells (HUVECs) in order to evaluate in vitro angiogenic activities. Their protein expressions, tagged with green fluorescent protein (GFP), were monitored by confocal microscopy. The functional activities were measured using wound- healing HUVEC migration assays. The number of migrated cells stimulated by both the expressed ANG1 and the VEGF in rAAV-infected HUVECs increased almost twice the number observed in the expressed GFP control. In vivo angiogenic activities of the expressed ANG1 or VEGF were determined using mouse angiogenesis assays. The angiogenic activities of ANG1 or VEGF expressed in the injected mice were increased by 1.36 and 2.16 times, respectively, compared to those of the expressed GFP control. These results demonstrate that the expressed ANG1 derived from rAAV infection has in vitro and in vivo angiogenic activities and suggest that the rAAV-ANG1 vector is a potential strategy for therapeutic angiogenesis.     

Antibacterial, Antiurease, and Antioxidant Activities of Some Arylidene Barbiturates

Some series of arylidene barbiturates and thiobarbiturates were evaluated for their antibacterial, antioxidant, and urease inhibition activities. The arylidene barbiturates and thiobarbiturates were tested for antimicrobial activity using the agar well diffusion technique against 13 bacteria. The synthesized compounds (1a–g) were screened for antiurease and antioxidant activities. The results showed that the synthesized compounds (1a–g) had effective antiurease, antioxidant, and antibacterial activities.     

Syntheses and biological activities of endothelin-1 analogs.

Endothelin-1 analogs replaced by various amino acids at position 21, namely [X21]-ET-1, were synthesized, and their agonistic vasoconstrictor activity on rat thoracic aortic strips and receptor binding activity on rat brain membrane fraction were examined to elucidate their structure-activity relationship. The vasoconstrictor activities of [Tyr21]- and [Phe21]-ET-1 were one order of magnitude smaller than that of ET-1, and those of [His21]-, [Gly21]-, [Ser21]-, [Ala21]- and [Lys21]-ET-1 were more than two orders of magnitude smaller than that of ET-1. On the other hand, the replacements by Ile, Glu, Gln and Pro resulted in distinguished losses of the vasoconstrictor activities. In addition, preincubation with these analogs did not blunt ET-1-induced vasoconstriction and showed no antagonistic activity. The binding inhibitory activities of these analogs against 125I-ET-1 were approximately conformable to the vasoconstrictor activities with only a slight exception. These findings demonstrate that the phenyl group at position 21 is important for both the vasoconstrictor activity and the receptor binding activity.